大理药业 (603963.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(大理药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 13,702,774.2622,683,181.3036,887,280.1331,888,407.4630,773,313.8429,865,609.2239,816,703.15
 营业收入(元) 13,702,774.2622,683,181.3036,887,280.1331,888,407.4630,773,313.8429,865,609.2239,816,703.15
二、营业总成本(元) 19,655,156.6630,682,985.9040,512,116.5239,166,503.0435,888,605.5736,590,328.0444,198,473.44
 营业成本(元) 8,772,314.8312,893,248.4016,293,150.1625,612,003.6410,012,984.059,314,205.5912,846,765.08
 研发费用(元) 78,979.05431,577.68151,998.65134,611.60251,179.77193,621.11347,576.35
 营业税金及附加(元) 632,523.28847,890.09894,903.621,003,777.58900,121.57473,364.75746,065.01
 销售费用(元) 6,128,501.7911,545,413.4418,779,591.0218,194,219.8216,908,082.3416,551,049.4422,032,480.29
 管理费用(元) 3,702,451.794,514,198.753,913,164.64-6,305,045.617,480,928.5410,038,857.608,217,414.01
 财务费用(元) 340,385.92450,657.54479,308.43526,936.01335,309.3019,229.558,172.70
  其中:利息费用(元) 365,250.51476,966.17523,322.15568,748.29381,271.5264,393.6963,650.89
  其中:利息收入(元) 28,085.3527,537.6552,367.8255,399.2941,625.2551,196.2060,630.93
 资产减值损失(元) ---2,735.71----
 信用减值损失(元) 116,073.76195,914.44-133,523.51-283,898.78505,523.6039,828.7511,383.64
三、其他经营收益
 加:公允价值变动收益(元) 1,080,217.611,167,359.501,335,357.97677,191.511,653,972.471,310,165.711,564,152.01
 加:投资收益(元) 102,558.80211,752.01110,415.25131,170.26---
 资产处置收益(元) --52,463.03----
 其他收益(元) 77,999.9921,999.9938,724.0438,499.9921,999.99108,866.1944,176.20
四、营业利润(元) -4,575,532.24-6,400,042.95-2,224,135.32-6,513,176.13-2,933,795.67-4,957,175.96-2,762,058.44
 加:营业外收入(元) 5,368.589,316.129,228.53230,189.5810,636.1119,096.668,909.85
 减:营业外支出(元) -252,061.78106,734.89138.08---
五、利润总额(元) -4,570,163.66-6,642,788.61-2,321,641.68-6,283,124.63-2,923,159.56-5,038,147.95-2,753,148.59
 减:所得税费用(元) 36,452.751,587,920.47230,002.03-58,739.1363,267.62245,083.31454,354.72
六、净利润(元) -4,606,616.41-8,230,709.08-2,551,643.71-6,224,385.50-2,986,427.18-5,283,231.26-3,207,503.31
(一)按经营持续性分类
  持续经营净利润(元) -4,606,616.41-8,230,709.08-2,551,643.71-6,224,385.50-2,986,427.18-5,283,231.26-3,207,503.31
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -4,606,616.41-8,230,709.08-2,551,643.71-6,224,385.50-2,986,427.18-5,283,231.26-3,207,503.31
 扣除非经常性损益后的净利润(元) -5,902,822.49-9,730,893.47-3,775,179.55-7,762,240.46-4,420,044.47-6,682,962.06-4,582,155.66
七、每股收益
 一、基本每股收益(元) -0.02-0.04-0.01-0.03-0.01-0.02-0.01
 二、稀释每股收益(元) -0.02-0.04-0.01-0.03-0.01-0.02-0.01
九、综合收益总额(元) -4,606,616.41-8,230,709.08-2,551,643.71-6,224,385.50-2,986,427.18-5,283,231.26-3,207,503.31
 归属于母公司所有者的综合收益总额(元) -4,606,616.41-8,230,709.08-2,551,643.71-6,224,385.50-2,986,427.18-5,283,231.26-3,207,503.31
公告日期 2023-10-272023-08-292023-04-282023-04-282022-10-282022-08-262022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院